EMJ Hematology 10 [Supplement 4] . 2022

In this issue

Myelodysplastic syndromes (MDS) are a rare group of blood disorders that can result in symptoms spanning from fatigue to easy bruising and bleeding. Based on a symposium that was part of the International Congress on Myelodysplastic Syndromes by the MDS Foundation, this article provides an overview of MDS.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.